Hovione’s TwinCaps® inhaler in Phase III clinical trials for influenza
Sales reach USD 103.7 million for the fiscal year ended March 31st 2008.
We’d welcome your feedback!
Thank you for visiting our website.
Would you like to take a few minutes to complete our short survey to let us know how we can improve your experience?